October 07, 2008
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for November 20, 2007 Subscribe to this News Feed  
 

Promising Results in Treating Facial Bruising From Injectables

Download this press release as an Adobe PDF document.

Physicians nationwide report promising results in treating facial bruising from injectable cosmetic treatments by using Pinoxide™, an active ingredient best known for treating under-eye circles. Pinoxide is a proprietary blend of bicyclic monoterpene dials (BMTd) created by AGI Dermatics and formulated in the company's Remergent Microcirculation Therapy product. Pinoxide has been clinically proven to speed blood flow, warm the skin, increase resistance to cold, and reduce dark under-eye symptoms. Additional research suggests Pinoxide may also contribute to promoting firmness and resiliency in the skin. Now, physicians are studying the ingredient's ability to heal bruising.
As a company, we are interested in how DNA controls skin development, how DNA gets damaged in skin, and how DNA can be repaired'

Freeport, NY (PRWEB) November 20, 2007 -- Physicians nationwide report promising results in treating facial bruising from injectable cosmetic treatments by using Pinoxide™, an active ingredient best known for treating under-eye circles.

AGI logo
AGI logo

Pinoxide is a proprietary blend of bicyclic monoterpene dials (BMTd) created by bio-pharmaceutical company AGI Dermatics, and formulated in the company's Remergent Microcirculation Therapy product. Pinoxide has been clinically proven to speed blood flow, warm the skin, increase resistance to cold, and reduce dark under-eye symptoms. Additional research suggests Pinoxide may also contribute to promoting firmness and resiliency in the skin. Now, physicians are studying the ingredient's ability to heal bruising.

Dr. Mark G. Rubin, a board-certified dermatologist currently practicing at the Lasky Clinic in Beverly Hills, is conducting the clinical trials on Pinoxide, applying the Microcirculation Therapy formula to the injection site immediately after use of skin fillers such as collagen, Restylane and Juvederm, or Botox.

"Anatomically speaking, dark circles are like bruises - so the science behind using Pinoxide for bruising makes total sense," said Dr. Rubin. "The skin discoloration during bruising is the result of blood leaking from damaged blood vessels and surfacing to the skin. Similarly, blood vessels under the eyes can burst, leading to the appearance of unattractive dark circles."

Leading dermatologists share Dr. Rubin's opinion. Dr. Thomas Francel, a board certified plastic surgeon, has found that application of MicroCirculation Therapy on his patients reduces the appearance of skin bruising, and decreases the amount of healing time for the bruise. Dr. Francel is the Chief of Plastic Surgery at St. John's Mercy Medical Center and an Associate Professor of Surgery at St. Louis University.

Injectable cosmetic treatments are among the five top most requested aesthetic treatments nationwide last year. According to the American Society for Aesthetic Plastic Surgery, more than 5 million women had injectable cosmetic treatments last year. Bruising is a common temporary side effect.

Built on two decades of scientific research in photobiology and DNA repair, Remergent is the next generation in skincare therapies. Applying biotechnology--in the form of patented liposome delivery systems--to biomimetic and select botanical ingredients, Remergent formulas are uniquely positioned to get active components into skin cells to repair damage, restore healthy response, and resist future injury.

"As a company, we are interested in how DNA controls skin development, how DNA gets damaged in skin, and how DNA can be repaired'" says Daniel Yarosh, Ph.D., founder and President of AGI Dermatics, formulator of the Remergent line of products. Other skin repair products offered by Remergent include advanced DNA Repair Formulas, Sunscreens, Skin Moisturizers, Post-peel Balms, Skin Brighteners, and Skin Stimulating Creams.

AGI Dermatics is the bio-pharmaceutical laboratory that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system, and cell-signaling in skin. The company's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in controlled clinical studies and published in dozens of peer-reviewed scientific and medical journals. www.agiderm.com

This press release has been distributed by SalemGlobal Internet Interactive Public Relations. Based in New York City, SalemGlobal (salemglobal.com) optimizes websites to increase traffic from search engines for the legal, healthcare, automotive and real estate industries, provides lead generation, and improves conversion of site visitors to buyers. Other services include general website marketing, search engine optimization, ecommerce solutions, content management systems, website hosting, web design and maintenance. Contact CEO Raphi Salem at 646-217-4733.

# # #

Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1Db3VwLUhhbGYtSG9yci1UaGlyLVplcm8=


See the original story at: http://www.prweb.com/releases/skincare/biopharmaceutical/prweb570662.htm
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
RAPHI SALEM
AGI Dermatics
6462174733
Email us Here
RAPHI SALEM
Visit Our Site
6462174733
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright